Fairvoy Private Wealth
BMY icon

Fairvoy Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Fairvoy Private Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$611K Buy
9,786
+4,733
+94% +$299K 0.12% 126
2026
Q2 		$291K Buy
5,053
+61
+1% +$3.5K 0.06% 174
2026
Q1 		$303K Sell
4,992
-297
-6% -$17.3K 0.07% 165
2025
Q4 		$285K Sell
5,289
-1,910
-27% -$91.9K 0.06% 156
2025
Q3 		$325K Sell
7,199
-418
-5% -$19.5K 0.07% 152
2025
Q2 		$353K Sell
7,617
-18,895
-71% -$928K 0.09% 138
2025
Q1 		$1.62M Buy
26,512
+4,587
+21% +$267K 0.44% 58
2024
Q4 		$1.24M Buy
+21,925
New +$1.23M 0.33% 66

Other funds holding BMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

Fairvoy Private Wealth's BMY Position: Q3 2026 in Review

Fairvoy Private Wealth increased its Bristol-Myers Squibb (BMY) stake by 94% in Q3 2026, buying an estimated $299K and bringing the position to 9,786 shares worth $611K. The position accounts for 0.12% of the portfolio, ranked #126.

Fairvoy Private Wealth first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.62M in Q1 2025. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Fairvoy Private Wealth held 9,786 shares of Bristol-Myers Squibb worth $611K as of Q3 2026.
  • Fairvoy Private Wealth bought 4,733 Bristol-Myers Squibb shares in Q3 2026, an estimated $299K.
  • Bristol-Myers Squibb made up 0.12% of Fairvoy Private Wealth's portfolio in Q3 2026, its #126 holding.
  • Fairvoy Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • Fairvoy Private Wealth's Bristol-Myers Squibb position peaked at $1.62M in Q1 2025.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Fairvoy Private Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.